A Recent Review of the Published Data on Probiotic Treatment of Atopic Dermatitis had this to say...
A recent review of the published data on probiotic treatment of atopic dermatitis (AD) in children revealed the need for further clinical studies to be done with newer probiotic preparations. Hence, a new randomized, double-blind, placebo-controlled, prospective trial was recently done and published in the American Journal of Clinical Dermatology using Lactobacillus acidophilus DDS-1, Bifidobacterium lactis UABLA-12 with fructo-oligosaccharide at a dosage of 5 billion colony-forming units twice daily for 8 weeks for the treatment of AD. The treatment trial was done on 90 children ages 1-3 years with moderate-to-severe AD. The results demonstrated a “significant clinical improvement in children with AD.”
Atopic dermatitis is an allergy-associated, reactive dermatitis common in children. It is usually treated with steroidal creams or immune suppressing topical agents and, at times, oral steroids. If we can lesson a child's exposure to these steroidal and immune-suppressing agents while inducing a "significant clinical improvement" in their AD in a safe and inexpensive manner, we should be actively pursuing this treatment.
About Clinical Shorts:
Clinical Shorts are a quick look at some of the most recent health-associated and nutritionally-relevant scientific research articles being published on a monthly basis. Clinical Shorts is your "quick glance" at scientifically supported nutritional and/or life style changes that -- if applied to your life now -- can positively affect your health and lesson your risks for disease.
Gerasimov SV, et al: Am J Clin Dermatol 2010; 11: 351-361